Martijn, J., Vosseberg, J., Guy, L., Offre, P
Some researchers report that hexarelin GH response diminishes significantly within 2-4 weeks of daily use
PIONEER 1 compared oral semaglutide with placebo [76], while PIONEER 24 compared oral semaglutide with the SGLT2i empagliflozin (25 mg once daily), the DPP-4 inhibitor sitagliptin (100 mg once daily), and the subcutaneous GLP-1RA liraglutide (1.8 mg once daily) [38, 39, 61, 62]
Beyond weight loss, semaglutide can improve metabolic markers such as blood sugar levels, cholesterol, and inflammation, reducing the risk of chronic diseases
However, there are major differences between these medications, including how they affect your body and how long you should use them
V.Ortega-RiberaM.LuftC.AntunesG